制剂

zhì jì
  • preparation
制剂制剂
制剂 [zhì jì]
  • [preparation] 制成的药物

  • 生物制剂

制剂[zhì jì]
  1. 以皂土为吸附剂,将花色素酶从粗果胶酶制剂中除去。分离效果受pH和皂土用量影响。

    Anthocyanase was removed from pectinase preparation by adsorption with bentonite .

  2. 目的:采用HPLC方法测定石杉碱甲及其制剂的含量。

    AIM : To establish HPLC method for the determination of huperzine A in its preparation .

  3. 强效纯可卡因是一种药效极强、容易使人上瘾的可卡因制剂。

    Crack is a highly potent and addictive derivative of cocaine .

  4. 有机食品是未使用人工化学制剂和杀虫剂的纯净食品。

    Organic food is unadulterated food produced without artificial chemicals or pesticides .

  5. 这种极其有效的新型植物制剂是从可乐果和海藻中提炼出来的。

    The most effective new botanicals are extracts from cola nut and marine algae .

  6. 有一位妇女剧痛难忍,不得不服用鸦片制剂来镇痛。

    One woman suffered such severe pain she had to take opiates to control it .

  7. 这类化学制剂,不管是芥子气还是神经瓦斯,都会被皮肤吸收。

    The chemical agent , whether it be mustard gas or nerve gas , can be absorbed by the skin .

  8. 用途:本品主要用作药物固体制剂,全粉末直接压片的干燥粘合剂,胶囊填充剂,崩解剂,湿法造粒粘合剂和着色的延展剂。

    Use : That is a padhesive with the powder Diecty , Compress tablets and replenisher , Disinteante , adhesive of the capsula .

  9. 但对于检测金黄色葡萄球菌滤液制剂中SET的实际含量几乎是相等的。

    But in practice content of detect SET nearly was equal .

  10. 两组病例均应用维生素K制剂。

    Two groups of cases both adopt vitamin K agents .

  11. 工业应用要求酶制剂具有高酶活性、良好的pH稳定性及热稳定性。

    Industrial applications require the enzymes having higher enzyme activity , excellent pH stability and thermal stability .

  12. 各药代动力学参数无显著性差异(P>0.05)。试验制剂氟康唑胶囊相对生物利用度F为(104.3±8.5)%。

    The relative bioavailability of the tested fluconazole was ( 104.3 ± 8.5 ) % .

  13. 研究黄芪成分F3新制剂对荷瘤小鼠生存期及实体瘤生长抑制的影响。

    The survival time and the tumor inhibition rate of Astragalus composition F3 new preparation were studied .

  14. 微生态制剂EM对蜜蜂微孢子体外发芽抑制实验

    Inhibition of Microbial Ecological Agents on Germination of Nosema apis in Vitro

  15. 用Excel软件计算药物制剂的溶出度

    Calculating Dissolution of Pharmaceutical Preparation by Microsoft Excel

  16. 结果表明最佳工艺所得制剂的包封率为86.7%,在4°C冰箱保存较为稳定。

    The result showed that the encapsulation ratio of the preparation with the optimum technique was 86.7 % and relatively stable at 4 ° C .

  17. 生物制剂在SBR中的工业化试验

    A Commercial Test of A Biological Agent on SBR

  18. 应用Bt生物制剂防治松毛虫试验

    Experiment on Controlling Dendrolimus with Bt Biological Agent

  19. TG酶制剂对鱼糜凝胶强度的影响

    Infection of Transglutaminase on surimi gel-strength

  20. 用NFS-60细胞株法对重组人粒细胞集落刺激因子制剂的活性测定研究

    Study on the Bioassay of Recombinant Human Granulocyte Colony Stimulating Factor

  21. 吡罗昔康PEG固体分散体中载体组成与制剂的体内外特性

    In vitro and in vivo characteristics of two dosage forms of piroxicam solid dispersion system with different PEG bases

  22. 说明在肉鸡生长早期(14d前)添加粗酶制剂和维生素C能显著促进生长,但在中后期促生长作用不显著。饲料中添加粗酶制剂与维生素C还可降低全程料肉质量比。

    The results also showed that coarse enzyme preparation and vitamin C added to the forage could decrease the mass ratio of forage and meat .

  23. 随着科学的进步,药物剂型和制剂研究已进入DDS时代。

    With the progress of science , drug formulations and preparation research have been entering the era of DDS .

  24. 目的:建立复方缓释制剂中双嘧达莫、阿司匹林含量测定及水杨酸限量检测的HPLC方法。

    Objective : To establish a HPLC method for determination of dipyridamole and aspirin , and develop a new method for limit of free salicylic acid .

  25. 结果表明:乳酸菌制剂处理除对青贮饲料的DM量和ADL含量无显著影响外(P>0.05),对其他指标均有显著影响(P<0.05)。

    The results showed that lactobacillus had a remarkable effect on the silage quality without the content of DM and ADL .

  26. 目的:测试PL型滤器对浓缩血小板制剂(PCs)中白细胞的滤除作用。

    Objectives : To determine the role of white blood cells-depletion with PL model filter in platelet concentrates ( PCs ) .

  27. 小剂量的氟制剂能中度增加骨量,用氟治疗6个月BMD就可有统计学意义。

    A little dose of fluoride can moderately increase the bone mass , BMD could show statistically significance in 6 months .

  28. 目的:研究受试制剂头孢克肟干混悬剂(A)、胶囊剂(B)和参比制剂(C,头孢克肟胶囊,世福素)的人体生物等效性。

    OBJECTIVE : To study the bioequivalence of suspension formulation of cefixime ( A ), capsule formulation of ce-fixime ( B ) and reference preparation ( C : Cefixime Capsules or Cefspan ) in human body .

  29. 因此,有必要开发新型5-FU口服缓释制剂,延长药物的半衰期,提高生物利用度。口服缓控释制剂研究概况

    So it is necessary to exploit new slow-release system for 5-FU . A review of research on oral sustained and controlled release preparations

  30. 选用12日龄蛋公雏90只,随机分成3组,Ⅰ组每羽肌注鸡血清制剂1mL;

    Male chicks of 12 day old were divided into three groups .